With the increase in the clinical stage, tumor blood vessels in DLBCL patients are gradually enriched, which is more conducive to tumor cell infiltration and growth, and the expression of bFGF in patients increases accordingly [14]. The gene discussed is FGF2; the disease is neoplasm.